Skip to main content
. 2023 Sep 8;13(11):2339–2355. doi: 10.1158/2159-8290.CD-23-0383

Figure 3.

Figure 3. Combinations of SHP2 with targeted therapy are currently being tested in the clinic. Targets are highlighted in red. For the purpose of clarity, the location of RAS is depicted away from the membrane. Created with BioRender.com.

Combinations of SHP2 with targeted therapy are currently being tested in the clinic. Targets are highlighted in red. For the purpose of clarity, the location of RAS is depicted away from the membrane. Created with BioRender.com.